2019-11-29 · Notice · 2019-25850
Determination of Regulatory Review Period for Purposes of Patent Extension; OZEMPIC
Semaglutide
Open attributed record →Federal Register publication year
12 documents attributed to FDA and HHS and published in 2019, connected only through exact reviewed peptide-name matches.
2019-11-29 · Notice · 2019-25850
Semaglutide
Open attributed record →2019-09-17 · Notice · 2019-20108
Plecanatide
Open attributed record →2019-09-09 · Notice · 2019-19347
Calcitonin salmon
Open attributed record →2019-09-03 · Notice · 2019-18932
Vasopressin
Open attributed record →2019-05-30 · Notice · 2019-11243
Leuprolide
Open attributed record →2019-05-16 · Notice · 2019-10165
Desmopressin
Open attributed record →2019-05-03 · Notice · 2019-09007
Dalbavancin
Open attributed record →2019-04-02 · Notice · 2019-06385
Daptomycin
Open attributed record →2019-03-13 · Rule · 2019-04226
Oxytocin
Open attributed record →2019-03-04 · Notice · 2019-03810
Vasopressin
Open attributed record →2019-02-25 · Notice · 2019-03129
Daptomycin
Open attributed record →2019-02-13 · Notice · 2019-02146
Peginesatide
Open attributed record →